Literature DB >> 30429590

Diagnosis and Management of Primary Biliary Cholangitis.

Zobair M Younossi1, David Bernstein2, Mitchell L Shiffman3, Paul Kwo4, W Ray Kim5, Kris V Kowdley6, Ira M Jacobson7.   

Abstract

Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune disease with a variable progressive course. PBC can cause debilitating symptoms including fatigue and pruritus and, if left untreated, is associated with a high risk of cirrhosis and related complications, liver failure, and death. Recent changes to the PBC landscape include a name change, updated guidelines for diagnosis and treatment as well as new treatment options that have recently become available. Practicing clinicians face many unanswered questions when managing PBC. To assist these healthcare providers in managing patients with PBC, the American College of Gastroenterology (ACG) Institute for Clinical Research & Education, in collaboration with the Chronic Liver Disease Foundation (CLDF), organized a panel of experts to evaluate and summarize the most current and relevant peer-reviewed literature regarding PBC. This, combined with the extensive experience and clinical expertise of this expert panel, led to the formation of this clinical guidance on the diagnosis and management of PBC.

Entities:  

Mesh:

Year:  2019        PMID: 30429590     DOI: 10.1038/s41395-018-0390-3

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Autoconversion of Autoimmune Liver Diseases.

Authors:  Barnabas Yik; Nimeesh Shah
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

Review 2.  Diagnosis and treatment of primary biliary cholangitis.

Authors:  Alena Laschtowitz; Rozanne C de Veer; Adriaan J Van der Meer; Christoph Schramm
Journal:  United European Gastroenterol J       Date:  2020-04-16       Impact factor: 4.623

Review 3.  The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.

Authors:  Dongwei Xu; Yizhu Tian; Qiang Xia; Bibo Ke
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 8.786

4.  Shear wave elastography and shear wave dispersion imaging in primary biliary cholangitis-a pilot study.

Authors:  Marten Schulz; Anne-Christin B Wilde; Münevver Demir; Tobias Müller; Frank Tacke; Alexander Wree
Journal:  Quant Imaging Med Surg       Date:  2022-02

5.  The Potential Effects of Diabetes Mellitus on Liver Fibrosis in Patients with Primary Biliary Cholangitis.

Authors:  Xu Liu; Hongqin Xu; Mengru Zhan; Junqi Niu
Journal:  Med Sci Monit       Date:  2019-08-17

Review 6.  Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?

Authors:  Chiara Pellicano; Giorgia Leodori; Giuseppe Pietro Innocenti; Antonietta Gigante; Edoardo Rosato
Journal:  Nutrients       Date:  2019-11-02       Impact factor: 5.717

7.  Ursodeoxycholic Acid at 18-22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis.

Authors:  Xinyu Xiang; Xiaoli Yang; Mengyi Shen; Chen Huang; Yifeng Liu; Xiaoli Fan; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-01-21

8.  A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis.

Authors:  Raj Vuppalanchi; Ma Saraí González-Huezo; Ramon Payan-Olivas; Linda E Muñoz-Espinosa; Farheen Shaikh; Jose L Pio Cruz-Lopez; Deven Parmar
Journal:  Clin Transl Gastroenterol       Date:  2021-03-26       Impact factor: 4.396

9.  Two decades of research on autoimmune liver disease in Turkey.

Authors:  Nurhan Demir; Nazım Ekin; Murat Torgutalp; Staffan Wahlin; Cumali Efe
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

Review 10.  Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents.

Authors:  Sho Hasegawa; Masato Yoneda; Yusuke Kurita; Asako Nogami; Yasushi Honda; Kunihiro Hosono; Atsushi Nakajima
Journal:  Drugs       Date:  2021-06-17       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.